Brian Lewis to Cyclin-Dependent Kinase Inhibitor p16
This is a "connection" page, showing publications Brian Lewis has written about Cyclin-Dependent Kinase Inhibitor p16.
Connection Strength
1.104
-
Chen YW, Chu HC, Shiah WJ, Chou CP, Klimstra DS, Lewis BC. p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells. PLoS One. 2013; 8(7):e69389.
Score: 0.418
-
Chen YW, Paliwal S, Draheim K, Grossman SR, Lewis BC. p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein. Cancer Res. 2008 Jan 15; 68(2):476-82.
Score: 0.285
-
Chen YW, Klimstra DS, Mongeau ME, Tatem JL, Boyartchuk V, Lewis BC. Loss of p53 and Ink4a/Arf cooperate in a cell autonomous fashion to induce metastasis of hepatocellular carcinoma cells. Cancer Res. 2007 Aug 15; 67(16):7589-96.
Score: 0.277
-
Morton JP, Klimstra DS, Mongeau ME, Lewis BC. Trp53 deletion stimulates the formation of metastatic pancreatic tumors. Am J Pathol. 2008 Apr; 172(4):1081-7.
Score: 0.072
-
Lewis BC, Klimstra DS, Varmus HE. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. Genes Dev. 2003 Dec 15; 17(24):3127-38.
Score: 0.054